Gulam Khan

View Scopus Profile

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Post Doctoral Fellow, Children's Hospital of Michigan, Detroit, MI

2007

Residency, Children's Hospital of Michigan, Detroit, MI

2005

Doctor of Medicine, Gandhi Medical College, Secunderabad, India

1983

Fingerprint

Dive into the research topics where Gulam Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Active
14 Finished

A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms
Khan, G.
Swarn Incorporated
4/1/22 → 2/14/24
Project: Research project
YKP3089C040: Open-Label Safety Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset (Focal) Seizures and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset (Focal) Seizures
Khan, G.
Pharmaceutical Research Associates
8/23/21 → 8/23/24
Project: Research project
A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms
Khan, G.
Syneos Health LLC
4/1/22 → 2/15/23
Project: Research project
E2007-G000-311: An Open-Label, Multicenter Study with an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension when Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to less
Khan, G. & Lightner, D.
Eisai Incorporated
4/6/17 → 2/19/18
Project: Research project
E2007-G000-238: An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy
Khan, G. & Lightner, D.
Eisai Incorporated
9/29/16 → 9/30/18
Project: Research project

5 Article
1 Comment/debate

Propofol-Related Infusion Syndrome in a Pediatric Patient With Intracerebral Hemorrhage
Sokola, M. S., O'connor, K. F., Sokola, B. S., Miller, B., Neltner, J. H., Lukins, D. & Khan, G., Oct 1 2021, In: Neurology: Clinical Practice. 11, 5, p. E742-E743
Research output: Contribution to journal › Article › peer-review
EEG findings in infants with neonatal abstinence syndrome presenting with clinical seizures
Palla, M. R., Khan, G., Haghighat, Z. M. & Bada, H., 2019, In: Frontiers in Pediatrics. 7, MAR, 111.
Research output: Contribution to journal › Article › peer-review

Open Access
8 Scopus citations
Brain tumors associated with psychogenic non-epileptic seizures: Case series
Garcia, C. R., Khan, G. Q., Morrow, A. M., Yadav, P., Lightner, D. D., Gilliam, F. G. & Villano, J. L., Jan 2018, In: Clinical Neurology and Neurosurgery. 164, p. 53-56 4 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Fístula arteriovenosa perimedular espinhal pediátrica
Translated title of the contribution: Pediatric spinal perimedullary arteriovenous fistulaVillamar, M. F., Khan, G. Q., Naranjo, V. I. & Alhajeri, A., Oct 2018, In: Arquivos de Neuro-Psiquiatria. 76, 10, p. 722-723 2 p.
Research output: Contribution to journal › Comment/debate

Open Access
2 Scopus citations
Manifestations of hypomelanosis of Ito
Albuja, A. C., Shrivastava, A. & Khan, G. Q., Oct 2018, In: Pediatrics and Neonatology. 59, 5, p. 536-537 2 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

Gulam Khan, MD

Personal profile

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms

YKP3089C040: Open-Label Safety Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset (Focal) Seizures and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset (Focal) Seizures

A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms

E2007-G000-311: An Open-Label, Multicenter Study with an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension when Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to less

E2007-G000-238: An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy

Propofol-Related Infusion Syndrome in a Pediatric Patient With Intracerebral Hemorrhage

EEG findings in infants with neonatal abstinence syndrome presenting with clinical seizures

Brain tumors associated with psychogenic non-epileptic seizures: Case series

Fístula arteriovenosa perimedular espinhal pediátrica

Manifestations of hypomelanosis of Ito

Gulam Khan, MD

Personal profile

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Grants and Contracts

Research output